Dose-volume response in acute dysphagia toxicity: Validating QUANTEC recommendations into clinical practice for head and neck radiotherapy

Acta Oncologica

Volumn 53, Issue 10, 2014, Pages 1305-1311

  Anderson, Nigel J ^a   Wada, Morikatsu ^a   Schneider Kolsky, Michal ^c   Rolfo, Maureen ^a   Joon, Daryl Lim ^a   Khoo, Vincent ^a,b,d,e  

^a AUSTIN HEALTH   (Australia)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL PRACTICE; COHORT ANALYSIS; DYSPHAGIA; FEMALE; GLOTTIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNX; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PROSPECTIVE STUDY; RADIATION INJURY; RADIATION RESPONSE; SYSTEMIC THERAPY; VALIDITY; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; CLASSIFICATION; COMPLICATION; DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; INCIDENCE; MIDDLE AGED; ORGANS AT RISK; PROCEDURES; STOMATITIS; VALIDATION STUDY;

CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LARYNX; MALE; MIDDLE AGED; ORGANS AT RISK; RADIOTHERAPY, INTENSITY-MODULATED; STOMATITIS;

EID: 84911909932     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.933874     Document Type: Article

References (23)

1. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109-22.
2. Marks LB, Ten Haken RK, Martel MK. Guest editor's introduction to QUANTEC: A users guide. Int J Radiat Oncol Biol Phys 2010; 76(3 Suppl): S1-2.
3. Dornfeld K, Simmons JR, Karnell L, Karnell M, Funk G, Yao M, et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet-and speech-related quality of life. Int J Radiat Oncol Biol Phys 2007; 68: 750-7.
4. Sanguineti G, Adapala P, Endres EJ, Brack C, Fiorino C, Sormani MP, et al. Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys 2007; 68: 741-9.
5. Rancati T, Fiorino C, Sanguineti G. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination. Int J Radiat Oncol Biol Phys 2009; 75: 915-23.
6. Rancati T, Schwarz M, Allen AM, Feng F, Popovtzer A, Mittal B, et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Physs 2010; 76 (3 Suppl): S64-9.
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-83.
8. Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squa-mous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010; 76: 403-9.
9. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-98.
10. Liu M, Moiseenko V, Agranovich A, Karvat A, Kwan W, Saleh ZH, et al. Normal tissue complication probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A test of the QUANTEC-recommended NTCP model. Acta Oncol 2010; 49: 1040-4.
11. Appelt AL, Vogelius IR, Farr KP, Khalil AA, Bentzen SM. Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors. Acta Oncol 2014; 53: 605-12.
12. Beetz I, Steenbakkers RJ, Chouvalova O, Leemans CR, Doornaert P, van der Laan BF, et al. The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia. Acta Oncol 2014; 53: 597-604.
13. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-98.
14. Strigari L, Pedicini P, D'Andrea M, Pinnaro P, Marucci L, Giordano C, et al. A new model for predicting acute mucosal toxicity in head-and-neck cancer patients undergoing radiotherapy with altered schedules. Int J Radiat Oncol Biol Phys 2012; 83: e697-702.
15. Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ, et al. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys 2008; 71: 1563-71.
16. O'Daniel JC, Garden AS, Schwartz DL, Wang H, Ang KK, Ahamad A, et al. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: Is what you plan what you get? Int J Radiat Oncol Biol Phys 2007; 69: 1290-6.
17. Zhou J, Fei D, Wu Q. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: What is the maximal dose? Int J Radiat Oncol Biol Phys 2003; 57: 673-82.
18. Bhide S, Urbano TG, Clark C, Hansen V, Adams E, Miles E, et al. Results of intensity modulated radiotherapy (IMRT) in laryngeal and hypopharyngeal cancer: A dose escalation study. Radiother Oncol 2007; 82(Suppl 1): S74-5.
19. La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K, et al. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009; 74: 1335-41.
20. Pignon JP, le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17, 346 patients. Radi-other Oncol 2009; 92: 4-14.
21. Raykher A, Correa L, Russo L, Brown P, Lee N, Pfister D, et al. The role of pretreatment percutaneous endoscopic gas-trostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. JPEN J Parenter Enteral Nutr 2009; 33: 404-10.
22. Murphy BA, Gilbert J. Dysphagia in head and neck cancer patients treated with radiation: Assessment, sequelae, and rehabilitation. Semin Radiat Oncol 2009; 19: 35-42.
23. Sanguineti G, Gunn GB, Parker BC, Endres EJ, Zeng J, Fiorino C. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endo-scopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011; 79: 52-9.